‘We took a huge risk’: the Indian firm making more Covid jabs than anyone
Adar Poonawalla, chief executive of the Serum Institute of India, on vaccines, regulation and what comes nextCoronavirus – latest updatesSee all our coronavirus coverageAdar Poonawalla, 40, is the chief executive of the Serum Institute of India (SII), …
Read More